This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gangadharam, P R Articles by Iseman, M D Search for Related Content PubMed PubMed Citation Articles by Gangadharam, P R Articles by Iseman, M D

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1988 June; 32(6): 886-889

Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions.

P R Gangadharam, L Kesavalu, P N Rao, V K Perumal and M D Iseman

National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

ABSTRACT

We studied the activity of amikacin against Mycobacterium avium complex strain 101 by using continuous-level, changing concentrations which simulated levels in serum in a patient, and pulsed exposures. Amikacin at a concentration of 5 or 15 micrograms/ml showed rapid bactericidal action following constant exposure of the organisms. With the in vitro model, using a peak concentration of 10 or 20 micrograms/ml, complete sterilization was obtained by day 7. In pulsed-exposure studies, a minimum period of contact of 72 or 96 h at a concentration of 10 micrograms/ml was needed for complete sterilization.

---

Antimicrob Agents Chemother. 1988 June; 32(6): 886-889

This article has been cited by other articles:

• Benson, C. A., Kessler, H. A., Pottage, J. C. Jr, Trenholme, G. M. (1991). Successful Treatment of Acquired Immunodeficiency Syndrome--Related Mycobacterium avium Complex Disease With a Multiple Drug Regimen Including Amikacin. Arch Intern Med 151: 582-585 [Abstract]